Project Updates

Sandoz

Location: Ljubljana, Slovenia 

Project type: Biopharmaceutical development centre 

Estimated completion: 2026 

Lek Pharmaceuticals, a pharmaceutical company based in Slovenia and a part of Sandoz, will build a state-of-the-art biosimilar technical development centre in Ljubljana, Slovenia, to support the growth of its biosimilar plans.

SCG Cell Therapy

Location: Singapore 

Project type: Cell therapy manufacturing facility 

Opened: July 2023 

SCG Cell Therapy opened a new first-of-its-kind cell therapy good-manufacturing-practice certified-(GMP) facility and R&D centre with the support of the Singapore Economic Development Board at its headquarters in Singapore.

Aphena Pharma

Location: Cookeville, Tennessee, US 

Project type: Solid dose division expansion 

Estimated Investment: $20m 

Aphena Pharma Solutions expanded its solid dose division in Cookeville with a $20m expansion and renovation, adding capacity for US FDA-compliant pharmaceutical packaging of solid dose and biologic products.

Go to article: Home | Digital dilemma in UK life sciences job marketGo to article: Editor's letterGo to article: ContentsGo to article: Mimotopes Company InsightGo to article: MimotopesGo to article: DatwylerGo to article: CytivaGo to article: bioMérieux Company InsightGo to article: BriefingGo to article: News in NumbersGo to article: Latest NewsGo to article: Latest DealsGo to article: Project UpdatesGo to article: Trends & InsightGo to article: PfanstiehlGo to article: SyntegonGo to article: In DepthGo to article: UK life sciences grapple with the job market’s digital dilemma Go to article: Telemedicine struggles to overcome diversity challenges in dermatology trials Go to article: Cancer treatment uncertainty: European nations struggle with drug shortages Go to article: From Europe to Latin America: Driving access to affordable biosimilars Go to article: Q&A: How the Henrietta Lacks settlement challenges biotech's view on ethics Go to article: Generative AI has the potential to revolutionise drug discovery Go to article: European PFAS ban would burden drug companies and packagers Go to article: Molnar-Institute Company InsightGo to article: Molnar-InstituteGo to article: Thematic TakeGo to article: Thematic Take: contentsGo to article: Foreword: unlocking robotics’ full potential Go to article: An introduction to robotics Go to article: A history of robotics  Go to article: The impact of robotics on the healthcare sector Go to article: Case studies: robotics in the pharmaceutical industry Go to article: Latest news: robotics in pharmaGo to article: Robotics: transforming cell and gene therapy manufacturingGo to article: Robotics innovation: Leading companies in microneedles for transdermal drug delivery Go to article: Deal activity related to robotics in the pharmaceutical industry since 2020 Go to article: Robotics hiring trends in the global pharmaceutical industry since 2020 Go to article: Robotics patent applications in the global pharmaceutical industry since 2020 Go to article: Mentions of robotics in pharmaceutical industry company filings since 2020 Go to article: GlobalData Thematic IntelligenceGo to article: Sponsored SupplementsGo to article: NiproGo to article: Watson MarlowGo to article: ListingsGo to article: EventsGo to article: AwardsGo to article: Buyer's GuidesGo to article: Next issue